nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—BAAT—liver—sarcoma	0.0177	0.0222	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—sarcoma	0.017	0.592	CbGdCrCtD
Glycine—ALAS2—hematopoietic system—sarcoma	0.0157	0.0197	CbGeAlD
Glycine—ALAS1—mammary gland—sarcoma	0.0147	0.0184	CbGeAlD
Glycine—GPR18—hematopoietic system—sarcoma	0.0145	0.0182	CbGeAlD
Glycine—GARS—mammary gland—sarcoma	0.0133	0.0168	CbGeAlD
Glycine—PIPOX—myometrium—sarcoma	0.0122	0.0154	CbGeAlD
Glycine—GLYATL2—bone marrow—sarcoma	0.012	0.0151	CbGeAlD
Glycine—GCAT—myometrium—sarcoma	0.0119	0.0149	CbGeAlD
Glycine—SHMT1—Vinblastine—Vincristine—sarcoma	0.0117	0.408	CbGdCrCtD
Glycine—SHMT2—mammary gland—sarcoma	0.0116	0.0146	CbGeAlD
Glycine—GLYATL1—liver—sarcoma	0.0114	0.0143	CbGeAlD
Glycine—GLDC—hematopoietic system—sarcoma	0.0112	0.0141	CbGeAlD
Glycine—PIPOX—seminal vesicle—sarcoma	0.011	0.0139	CbGeAlD
Glycine—GLRB—mammary gland—sarcoma	0.0109	0.0137	CbGeAlD
Glycine—GCAT—seminal vesicle—sarcoma	0.0107	0.0135	CbGeAlD
Glycine—GLYAT—liver—sarcoma	0.0107	0.0135	CbGeAlD
Glycine—SHMT1—mammary gland—sarcoma	0.0106	0.0133	CbGeAlD
Glycine—ALAS1—myometrium—sarcoma	0.0104	0.0131	CbGeAlD
Glycine—GPR18—lymphoid tissue—sarcoma	0.0102	0.0128	CbGeAlD
Glycine—ALAS2—bone marrow—sarcoma	0.01	0.0126	CbGeAlD
Glycine—GPR18—tendon—sarcoma	0.00959	0.0121	CbGeAlD
Glycine—GARS—myometrium—sarcoma	0.00947	0.0119	CbGeAlD
Glycine—SLC32A1—testis—sarcoma	0.00945	0.0119	CbGeAlD
Glycine—ALAS1—seminal vesicle—sarcoma	0.00939	0.0118	CbGeAlD
Glycine—GPR18—bone marrow—sarcoma	0.00929	0.0117	CbGeAlD
Glycine—SLC6A9—testis—sarcoma	0.00912	0.0115	CbGeAlD
Glycine—GRIN3B—testis—sarcoma	0.00912	0.0115	CbGeAlD
Glycine—GARS—embryo—sarcoma	0.00911	0.0115	CbGeAlD
Glycine—ALAS1—hematopoietic system—sarcoma	0.00893	0.0112	CbGeAlD
Glycine—GCAT—skin of body—sarcoma	0.00886	0.0111	CbGeAlD
Glycine—ALAS2—testis—sarcoma	0.00858	0.0108	CbGeAlD
Glycine—GARS—seminal vesicle—sarcoma	0.00856	0.0108	CbGeAlD
Glycine—SHMT2—myometrium—sarcoma	0.00824	0.0104	CbGeAlD
Glycine—GARS—hematopoietic system—sarcoma	0.00813	0.0102	CbGeAlD
Glycine—ALAS2—liver—sarcoma	0.00811	0.0102	CbGeAlD
Glycine—GPR18—testis—sarcoma	0.00794	0.00998	CbGeAlD
Glycine—GARS—connective tissue—sarcoma	0.00783	0.00985	CbGeAlD
Glycine—GATM—hematopoietic system—sarcoma	0.00772	0.00971	CbGeAlD
Glycine—GCSH—testis—sarcoma	0.00744	0.00936	CbGeAlD
Glycine—AGXT—liver—sarcoma	0.00734	0.00923	CbGeAlD
Glycine—GARS—smooth muscle tissue—sarcoma	0.00716	0.00901	CbGeAlD
Glycine—SHMT2—hematopoietic system—sarcoma	0.00707	0.0089	CbGeAlD
Glycine—GARS—skin of body—sarcoma	0.00707	0.00889	CbGeAlD
Glycine—GCSH—liver—sarcoma	0.00703	0.00884	CbGeAlD
Glycine—PIPOX—tendon—sarcoma	0.00695	0.00874	CbGeAlD
Glycine—ALAS1—cardiac atrium—sarcoma	0.00678	0.00853	CbGeAlD
Glycine—SHMT1—seminal vesicle—sarcoma	0.00678	0.00852	CbGeAlD
Glycine—ALAS1—uterus—sarcoma	0.00674	0.00848	CbGeAlD
Glycine—GCAT—tendon—sarcoma	0.00674	0.00848	CbGeAlD
Glycine—SLC6A9—lymph node—sarcoma	0.00661	0.00832	CbGeAlD
Glycine—AGXT2—testis—sarcoma	0.0066	0.0083	CbGeAlD
Glycine—GCAT—bone marrow—sarcoma	0.00653	0.00821	CbGeAlD
Glycine—SHMT1—hematopoietic system—sarcoma	0.00644	0.0081	CbGeAlD
Glycine—AGXT2—liver—sarcoma	0.00624	0.00784	CbGeAlD
Glycine—GARS—cardiac atrium—sarcoma	0.00617	0.00777	CbGeAlD
Glycine—GLDC—testis—sarcoma	0.00616	0.00775	CbGeAlD
Glycine—SHMT2—skin of body—sarcoma	0.00615	0.00774	CbGeAlD
Glycine—GNMT—liver—sarcoma	0.00615	0.00773	CbGeAlD
Glycine—Encephalopathy—Thiotepa—sarcoma	0.00614	0.0453	CcSEcCtD
Glycine—GARS—uterus—sarcoma	0.00614	0.00773	CbGeAlD
Glycine—ALAS1—tendon—sarcoma	0.00591	0.00743	CbGeAlD
Glycine—GATM—cardiac atrium—sarcoma	0.00586	0.00737	CbGeAlD
Glycine—GATM—uterus—sarcoma	0.00583	0.00733	CbGeAlD
Glycine—GLDC—liver—sarcoma	0.00583	0.00733	CbGeAlD
Glycine—PIPOX—testis—sarcoma	0.00575	0.00724	CbGeAlD
Glycine—GPR18—lymph node—sarcoma	0.00575	0.00724	CbGeAlD
Glycine—GARS—lymphoid tissue—sarcoma	0.00572	0.0072	CbGeAlD
Glycine—ALAS1—bone marrow—sarcoma	0.00572	0.0072	CbGeAlD
Glycine—GSS—myometrium—sarcoma	0.00563	0.00708	CbGeAlD
Glycine—GCAT—testis—sarcoma	0.00558	0.00702	CbGeAlD
Glycine—PIPOX—liver—sarcoma	0.00544	0.00684	CbGeAlD
Glycine—GCSH—lymph node—sarcoma	0.00539	0.00678	CbGeAlD
Glycine—GARS—tendon—sarcoma	0.00538	0.00677	CbGeAlD
Glycine—SHMT2—uterus—sarcoma	0.00534	0.00672	CbGeAlD
Glycine—GCAT—liver—sarcoma	0.00528	0.00664	CbGeAlD
Glycine—GARS—bone marrow—sarcoma	0.00521	0.00656	CbGeAlD
Glycine—GSS—seminal vesicle—sarcoma	0.00509	0.0064	CbGeAlD
Glycine—SHMT2—lymphoid tissue—sarcoma	0.00498	0.00626	CbGeAlD
Glycine—ALAS1—testis—sarcoma	0.00489	0.00615	CbGeAlD
Glycine—GSS—hematopoietic system—sarcoma	0.00484	0.00608	CbGeAlD
Glycine—SHMT2—tendon—sarcoma	0.00468	0.00589	CbGeAlD
Glycine—ALAS1—liver—sarcoma	0.00463	0.00582	CbGeAlD
Glycine—SHMT2—bone marrow—sarcoma	0.00453	0.0057	CbGeAlD
Glycine—SHMT1—lymphoid tissue—sarcoma	0.00453	0.0057	CbGeAlD
Glycine—GLDC—lymph node—sarcoma	0.00447	0.00562	CbGeAlD
Glycine—GARS—testis—sarcoma	0.00446	0.0056	CbGeAlD
Glycine—GRIN2C—testis—sarcoma	0.00438	0.00551	CbGeAlD
Glycine—SHMT1—tendon—sarcoma	0.00426	0.00536	CbGeAlD
Glycine—GSS—smooth muscle tissue—sarcoma	0.00426	0.00536	CbGeAlD
Glycine—GATM—testis—sarcoma	0.00423	0.00532	CbGeAlD
Glycine—GARS—liver—sarcoma	0.00421	0.0053	CbGeAlD
Glycine—GSS—skin of body—sarcoma	0.0042	0.00529	CbGeAlD
Glycine—SLC36A1—uterus—sarcoma	0.00415	0.00522	CbGeAlD
Glycine—SHMT1—bone marrow—sarcoma	0.00413	0.00519	CbGeAlD
Glycine—GCAT—lymph node—sarcoma	0.00405	0.00509	CbGeAlD
Glycine—GATM—liver—sarcoma	0.004	0.00503	CbGeAlD
Glycine—SHMT2—testis—sarcoma	0.00388	0.00488	CbGeAlD
Glycine—GSS—cardiac atrium—sarcoma	0.00367	0.00462	CbGeAlD
Glycine—SHMT2—liver—sarcoma	0.00367	0.00461	CbGeAlD
Glycine—GRIN2A—tendon—sarcoma	0.00366	0.0046	CbGeAlD
Glycine—GSS—uterus—sarcoma	0.00365	0.00459	CbGeAlD
Glycine—SLC36A1—tendon—sarcoma	0.00364	0.00457	CbGeAlD
Glycine—ALAS1—lymph node—sarcoma	0.00355	0.00446	CbGeAlD
Glycine—SLC16A10—hematopoietic system—sarcoma	0.00354	0.00445	CbGeAlD
Glycine—SHMT1—testis—sarcoma	0.00353	0.00444	CbGeAlD
Glycine—SLC36A1—bone marrow—sarcoma	0.00352	0.00443	CbGeAlD
Glycine—SHMT1—liver—sarcoma	0.00334	0.0042	CbGeAlD
Glycine—GARS—lymph node—sarcoma	0.00323	0.00406	CbGeAlD
Glycine—Cardiovascular disorder—Etoposide—sarcoma	0.00322	0.0238	CcSEcCtD
Glycine—GSS—tendon—sarcoma	0.0032	0.00403	CbGeAlD
Glycine—Coma—Vincristine—sarcoma	0.0032	0.0236	CcSEcCtD
Glycine—GSS—bone marrow—sarcoma	0.0031	0.0039	CbGeAlD
Glycine—GATM—lymph node—sarcoma	0.00307	0.00386	CbGeAlD
Glycine—GRIN2A—testis—sarcoma	0.00303	0.00381	CbGeAlD
Glycine—SLC36A1—testis—sarcoma	0.00301	0.00379	CbGeAlD
Glycine—Polyuria—Vincristine—sarcoma	0.00289	0.0213	CcSEcCtD
Glycine—SLC36A1—liver—sarcoma	0.00285	0.00358	CbGeAlD
Glycine—SHMT2—lymph node—sarcoma	0.00281	0.00353	CbGeAlD
Glycine—Urinary retention—Thiotepa—sarcoma	0.00272	0.0201	CcSEcCtD
Glycine—Dehydration—Thiotepa—sarcoma	0.00266	0.0196	CcSEcCtD
Glycine—GSS—testis—sarcoma	0.00265	0.00333	CbGeAlD
Glycine—GLRB—lymph node—sarcoma	0.00263	0.00331	CbGeAlD
Glycine—SHMT2—Vitamin B12 Metabolism—HBA1—sarcoma	0.00262	0.0647	CbGpPWpGaD
Glycine—SHMT1—lymph node—sarcoma	0.00256	0.00322	CbGeAlD
Glycine—Hyponatraemia—Vincristine—sarcoma	0.00255	0.0188	CcSEcCtD
Glycine—GSS—liver—sarcoma	0.00251	0.00315	CbGeAlD
Glycine—SLC16A10—lymphoid tissue—sarcoma	0.00249	0.00314	CbGeAlD
Glycine—Hyponatraemia—Mitoxantrone—sarcoma	0.00248	0.0183	CcSEcCtD
Glycine—Urinary retention—Vincristine—sarcoma	0.00241	0.0178	CcSEcCtD
Glycine—Dehydration—Vincristine—sarcoma	0.00236	0.0174	CcSEcCtD
Glycine—SLC16A10—tendon—sarcoma	0.00234	0.00295	CbGeAlD
Glycine—Dehydration—Mitoxantrone—sarcoma	0.0023	0.017	CcSEcCtD
Glycine—Lung disorder—Epirubicin—sarcoma	0.00224	0.0165	CcSEcCtD
Glycine—SLC36A1—lymph node—sarcoma	0.00218	0.00274	CbGeAlD
Glycine—SHMT2—Folate Metabolism—HBA1—sarcoma	0.00214	0.0526	CbGpPWpGaD
Glycine—Lung disorder—Doxorubicin—sarcoma	0.00208	0.0153	CcSEcCtD
Glycine—SLC16A10—testis—sarcoma	0.00194	0.00244	CbGeAlD
Glycine—GSS—lymph node—sarcoma	0.00192	0.00242	CbGeAlD
Glycine—ALAS1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.0019	0.0469	CbGpPWpGaD
Glycine—SLC16A10—liver—sarcoma	0.00184	0.00231	CbGeAlD
Glycine—Cardiovascular disorder—Epirubicin—sarcoma	0.00181	0.0133	CcSEcCtD
Glycine—Chills—Thiotepa—sarcoma	0.00178	0.0131	CcSEcCtD
Glycine—Chills—Dactinomycin—sarcoma	0.00176	0.013	CcSEcCtD
Glycine—Rhinitis—Mitoxantrone—sarcoma	0.00171	0.0126	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—sarcoma	0.00167	0.0123	CcSEcCtD
Glycine—Back pain—Thiotepa—sarcoma	0.00167	0.0123	CcSEcCtD
Glycine—Vision blurred—Thiotepa—sarcoma	0.00162	0.012	CcSEcCtD
Glycine—Salivary hypersecretion—Epirubicin—sarcoma	0.00154	0.0114	CcSEcCtD
Glycine—Chills—Mitoxantrone—sarcoma	0.00153	0.0113	CcSEcCtD
Glycine—Convulsion—Thiotepa—sarcoma	0.00149	0.011	CcSEcCtD
Glycine—Back pain—Vincristine—sarcoma	0.00148	0.0109	CcSEcCtD
Glycine—Coma—Epirubicin—sarcoma	0.00145	0.0107	CcSEcCtD
Glycine—Back pain—Mitoxantrone—sarcoma	0.00144	0.0106	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—sarcoma	0.00143	0.0105	CcSEcCtD
Glycine—SLC16A10—lymph node—sarcoma	0.00141	0.00177	CbGeAlD
Glycine—Vision blurred—Mitoxantrone—sarcoma	0.0014	0.0103	CcSEcCtD
Glycine—Oedema—Dactinomycin—sarcoma	0.0014	0.0103	CcSEcCtD
Glycine—Vertigo—Vincristine—sarcoma	0.00137	0.0101	CcSEcCtD
Glycine—Tachycardia—Thiotepa—sarcoma	0.00137	0.0101	CcSEcCtD
Glycine—Coma—Doxorubicin—sarcoma	0.00134	0.0099	CcSEcCtD
Glycine—Thrombophlebitis—Epirubicin—sarcoma	0.00133	0.00982	CcSEcCtD
Glycine—Convulsion—Vincristine—sarcoma	0.00132	0.00977	CcSEcCtD
Glycine—Convulsion—Mitoxantrone—sarcoma	0.00129	0.00951	CcSEcCtD
Glycine—GRIN2C—CREB phosphorylation through the activation of CaMKII—CREB1—sarcoma	0.00128	0.0317	CbGpPWpGaD
Glycine—Chills—Etoposide—sarcoma	0.00128	0.00941	CcSEcCtD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—NPM1—sarcoma	0.00127	0.0312	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—HBA1—sarcoma	0.00126	0.031	CbGpPWpGaD
Glycine—Oedema—Vincristine—sarcoma	0.00125	0.0092	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—sarcoma	0.00123	0.00908	CcSEcCtD
Glycine—Oedema—Mitoxantrone—sarcoma	0.00122	0.00896	CcSEcCtD
Glycine—Pain—Thiotepa—sarcoma	0.0012	0.00887	CcSEcCtD
Glycine—Back pain—Etoposide—sarcoma	0.0012	0.00883	CcSEcCtD
Glycine—Pain—Dactinomycin—sarcoma	0.00119	0.0088	CcSEcCtD
Glycine—Tachycardia—Mitoxantrone—sarcoma	0.00119	0.00874	CcSEcCtD
Glycine—Hypotension—Vincristine—sarcoma	0.00117	0.0086	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—sarcoma	0.00116	0.00853	CcSEcCtD
Glycine—Hypotension—Mitoxantrone—sarcoma	0.00114	0.00837	CcSEcCtD
Glycine—Urticaria—Thiotepa—sarcoma	0.00112	0.00824	CcSEcCtD
Glycine—Vertigo—Etoposide—sarcoma	0.00111	0.0082	CcSEcCtD
Glycine—Convulsion—Etoposide—sarcoma	0.00107	0.00791	CcSEcCtD
Glycine—Dehydration—Epirubicin—sarcoma	0.00107	0.0079	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—sarcoma	0.00107	0.0079	CcSEcCtD
Glycine—ALAS1—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.00107	0.0263	CbGpPWpGaD
Glycine—Pain—Vincristine—sarcoma	0.00107	0.00787	CcSEcCtD
Glycine—ALAS1—Transcriptional activation of mitochondrial biogenesis—CREB1—sarcoma	0.00105	0.0259	CbGpPWpGaD
Glycine—Pain—Mitoxantrone—sarcoma	0.00104	0.00766	CcSEcCtD
Glycine—Hypersensitivity—Thiotepa—sarcoma	0.00104	0.00764	CcSEcCtD
Glycine—Hypersensitivity—Dactinomycin—sarcoma	0.00103	0.00759	CcSEcCtD
Glycine—Dehydration—Doxorubicin—sarcoma	0.000992	0.00731	CcSEcCtD
Glycine—Tachycardia—Etoposide—sarcoma	0.000987	0.00727	CcSEcCtD
Glycine—GRIN2A—CREB phosphorylation through the activation of CaMKII—CREB1—sarcoma	0.000981	0.0242	CbGpPWpGaD
Glycine—Angina pectoris—Epirubicin—sarcoma	0.000971	0.00715	CcSEcCtD
Glycine—Urticaria—Mitoxantrone—sarcoma	0.000965	0.00712	CcSEcCtD
Glycine—Diarrhoea—Thiotepa—sarcoma	0.000963	0.0071	CcSEcCtD
Glycine—Diarrhoea—Dactinomycin—sarcoma	0.000956	0.00704	CcSEcCtD
Glycine—Hypotension—Etoposide—sarcoma	0.000945	0.00696	CcSEcCtD
Glycine—Dizziness—Thiotepa—sarcoma	0.000931	0.00686	CcSEcCtD
Glycine—Hypersensitivity—Vincristine—sarcoma	0.000919	0.00678	CcSEcCtD
Glycine—ALAS1—Mitochondrial biogenesis—CREB1—sarcoma	0.000907	0.0224	CbGpPWpGaD
Glycine—Angina pectoris—Doxorubicin—sarcoma	0.000898	0.00662	CcSEcCtD
Glycine—Hypersensitivity—Mitoxantrone—sarcoma	0.000895	0.0066	CcSEcCtD
Glycine—Vomiting—Thiotepa—sarcoma	0.000895	0.0066	CcSEcCtD
Glycine—Vomiting—Dactinomycin—sarcoma	0.000888	0.00655	CcSEcCtD
Glycine—Pain—Etoposide—sarcoma	0.000864	0.00637	CcSEcCtD
Glycine—Diarrhoea—Vincristine—sarcoma	0.000854	0.00629	CcSEcCtD
Glycine—GRIN2C—CREB phosphorylation through the activation of Ras—CREB1—sarcoma	0.000838	0.0206	CbGpPWpGaD
Glycine—Nausea—Thiotepa—sarcoma	0.000836	0.00616	CcSEcCtD
Glycine—Diarrhoea—Mitoxantrone—sarcoma	0.000831	0.00613	CcSEcCtD
Glycine—Nausea—Dactinomycin—sarcoma	0.00083	0.00612	CcSEcCtD
Glycine—Dizziness—Vincristine—sarcoma	0.000825	0.00608	CcSEcCtD
Glycine—Urticaria—Etoposide—sarcoma	0.000803	0.00592	CcSEcCtD
Glycine—Rhinitis—Epirubicin—sarcoma	0.0008	0.00589	CcSEcCtD
Glycine—Vomiting—Vincristine—sarcoma	0.000793	0.00585	CcSEcCtD
Glycine—GRIN2C—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.000774	0.0191	CbGpPWpGaD
Glycine—Vomiting—Mitoxantrone—sarcoma	0.000773	0.0057	CcSEcCtD
Glycine—Visual impairment—Epirubicin—sarcoma	0.000769	0.00567	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—sarcoma	0.000745	0.00549	CcSEcCtD
Glycine—Nausea—Vincristine—sarcoma	0.000741	0.00546	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—sarcoma	0.00074	0.00545	CcSEcCtD
Glycine—Nausea—Mitoxantrone—sarcoma	0.000722	0.00532	CcSEcCtD
Glycine—Chills—Epirubicin—sarcoma	0.000716	0.00528	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—sarcoma	0.000711	0.00524	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IL2—sarcoma	0.000694	0.0171	CbGpPWpGaD
Glycine—Diarrhoea—Etoposide—sarcoma	0.000692	0.0051	CcSEcCtD
Glycine—GRIN2C—Post NMDA receptor activation events—CREB1—sarcoma	0.000689	0.017	CbGpPWpGaD
Glycine—Back pain—Epirubicin—sarcoma	0.000672	0.00495	CcSEcCtD
Glycine—Dizziness—Etoposide—sarcoma	0.000668	0.00493	CcSEcCtD
Glycine—Chills—Doxorubicin—sarcoma	0.000662	0.00488	CcSEcCtD
Glycine—Vision blurred—Epirubicin—sarcoma	0.000654	0.00482	CcSEcCtD
Glycine—Vomiting—Etoposide—sarcoma	0.000643	0.00474	CcSEcCtD
Glycine—GRIN2A—CREB phosphorylation through the activation of Ras—CREB1—sarcoma	0.00064	0.0158	CbGpPWpGaD
Glycine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.000635	0.0157	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—CXCR4—sarcoma	0.000634	0.0156	CbGpPWpGaD
Glycine—Vertigo—Epirubicin—sarcoma	0.000624	0.0046	CcSEcCtD
Glycine—Back pain—Doxorubicin—sarcoma	0.000621	0.00458	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—sarcoma	0.000605	0.00446	CcSEcCtD
Glycine—Convulsion—Epirubicin—sarcoma	0.000602	0.00443	CcSEcCtD
Glycine—Nausea—Etoposide—sarcoma	0.0006	0.00443	CcSEcCtD
Glycine—GRIN2A—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.000591	0.0146	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000589	0.0145	CbGpPWpGaD
Glycine—Vertigo—Doxorubicin—sarcoma	0.000577	0.00425	CcSEcCtD
Glycine—Oedema—Epirubicin—sarcoma	0.000567	0.00418	CcSEcCtD
Glycine—GARS—Gene Expression—FUS—sarcoma	0.000563	0.0139	CbGpPWpGaD
Glycine—Convulsion—Doxorubicin—sarcoma	0.000557	0.0041	CcSEcCtD
Glycine—Tachycardia—Epirubicin—sarcoma	0.000553	0.00408	CcSEcCtD
Glycine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.000534	0.0131	CbGpPWpGaD
Glycine—Hypotension—Epirubicin—sarcoma	0.000529	0.0039	CcSEcCtD
Glycine—GRIN2A—Post NMDA receptor activation events—CREB1—sarcoma	0.000526	0.013	CbGpPWpGaD
Glycine—Oedema—Doxorubicin—sarcoma	0.000524	0.00386	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—sarcoma	0.000512	0.00377	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000504	0.0124	CbGpPWpGaD
Glycine—Hypotension—Doxorubicin—sarcoma	0.00049	0.00361	CcSEcCtD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.000485	0.0119	CbGpPWpGaD
Glycine—Pain—Epirubicin—sarcoma	0.000485	0.00357	CcSEcCtD
Glycine—Urticaria—Epirubicin—sarcoma	0.00045	0.00332	CcSEcCtD
Glycine—Pain—Doxorubicin—sarcoma	0.000448	0.0033	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—TP53—sarcoma	0.000445	0.011	CbGpPWpGaD
Glycine—Hypersensitivity—Epirubicin—sarcoma	0.000417	0.00308	CcSEcCtD
Glycine—Urticaria—Doxorubicin—sarcoma	0.000416	0.00307	CcSEcCtD
Glycine—ALAS1—Organelle biogenesis and maintenance—CREB1—sarcoma	0.000412	0.0101	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—IL2—sarcoma	0.000409	0.0101	CbGpPWpGaD
Glycine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.000407	0.01	CbGpPWpGaD
Glycine—Diarrhoea—Epirubicin—sarcoma	0.000388	0.00286	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—sarcoma	0.000386	0.00285	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CXCR4—sarcoma	0.000384	0.00946	CbGpPWpGaD
Glycine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00038	0.00937	CbGpPWpGaD
Glycine—Dizziness—Epirubicin—sarcoma	0.000375	0.00276	CcSEcCtD
Glycine—SLC32A1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000369	0.00909	CbGpPWpGaD
Glycine—Vomiting—Epirubicin—sarcoma	0.00036	0.00266	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—sarcoma	0.000359	0.00264	CcSEcCtD
Glycine—Dizziness—Doxorubicin—sarcoma	0.000347	0.00256	CcSEcCtD
Glycine—Nausea—Epirubicin—sarcoma	0.000337	0.00248	CcSEcCtD
Glycine—Vomiting—Doxorubicin—sarcoma	0.000333	0.00246	CcSEcCtD
Glycine—GRIN2C—Post NMDA receptor activation events—HRAS—sarcoma	0.000313	0.00771	CbGpPWpGaD
Glycine—Nausea—Doxorubicin—sarcoma	0.000311	0.0023	CcSEcCtD
Glycine—SLC32A1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000305	0.00752	CbGpPWpGaD
Glycine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00029	0.00716	CbGpPWpGaD
Glycine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.000288	0.00711	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—CREB1—sarcoma	0.000283	0.00696	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—sarcoma	0.000277	0.00682	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—sarcoma	0.000263	0.00647	CbGpPWpGaD
Glycine—GRIN2A—Post NMDA receptor activation events—HRAS—sarcoma	0.000239	0.00589	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000238	0.00586	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—MDM2—sarcoma	0.000234	0.00576	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—sarcoma	0.000227	0.0056	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ENO2—sarcoma	0.000225	0.00555	CbGpPWpGaD
Glycine—ALAS2—Metabolism—HBA1—sarcoma	0.000224	0.00552	CbGpPWpGaD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.00022	0.00543	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCR4—sarcoma	0.000217	0.00535	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCR4—sarcoma	0.000197	0.00486	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000197	0.00485	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PLCG1—sarcoma	0.000191	0.00471	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TLE1—sarcoma	0.000183	0.0045	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000182	0.00447	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—CREB1—sarcoma	0.000179	0.00441	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—sarcoma	0.000178	0.0044	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ENO2—sarcoma	0.000171	0.00421	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ENO2—sarcoma	0.000171	0.00421	CbGpPWpGaD
Glycine—GATM—Metabolism—ENO2—sarcoma	0.000171	0.00421	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ENO2—sarcoma	0.000171	0.00421	CbGpPWpGaD
Glycine—GATM—Metabolism—HBA1—sarcoma	0.00017	0.00418	CbGpPWpGaD
Glycine—GLYAT—Metabolism—HBA1—sarcoma	0.00017	0.00418	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—HBA1—sarcoma	0.00017	0.00418	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—HBA1—sarcoma	0.00017	0.00418	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000167	0.00413	CbGpPWpGaD
Glycine—BAAT—Metabolism—ENO2—sarcoma	0.000163	0.00402	CbGpPWpGaD
Glycine—BAAT—Metabolism—HBA1—sarcoma	0.000162	0.00399	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFC—sarcoma	0.000154	0.0038	CbGpPWpGaD
Glycine—SHMT1—Disease—TLE1—sarcoma	0.000154	0.00379	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.00015	0.0037	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—MDM2—sarcoma	0.000148	0.00364	CbGpPWpGaD
Glycine—AGXT—Metabolism—ENO2—sarcoma	0.000145	0.00358	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PLCG1—sarcoma	0.000145	0.00357	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PLCG1—sarcoma	0.000145	0.00357	CbGpPWpGaD
Glycine—GATM—Metabolism—PLCG1—sarcoma	0.000145	0.00357	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PLCG1—sarcoma	0.000145	0.00357	CbGpPWpGaD
Glycine—AGXT—Metabolism—HBA1—sarcoma	0.000144	0.00356	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ENO2—sarcoma	0.000141	0.00347	CbGpPWpGaD
Glycine—ALAS1—Metabolism—HBA1—sarcoma	0.00014	0.00344	CbGpPWpGaD
Glycine—SHMT1—Disease—NPM1—sarcoma	0.000139	0.00342	CbGpPWpGaD
Glycine—BAAT—Metabolism—PLCG1—sarcoma	0.000138	0.00341	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—CREB1—sarcoma	0.000137	0.00338	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—CREB1—sarcoma	0.000136	0.00336	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—sarcoma	0.000136	0.00336	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—HRAS—sarcoma	0.000128	0.00316	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ENO2—sarcoma	0.000123	0.00304	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FLT1—sarcoma	0.000123	0.00304	CbGpPWpGaD
Glycine—AGXT—Metabolism—PLCG1—sarcoma	0.000123	0.00304	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HBA1—sarcoma	0.000123	0.00302	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PLCG1—sarcoma	0.000121	0.00299	CbGpPWpGaD
Glycine—SHMT1—Disease—ENO2—sarcoma	0.00012	0.00296	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PLCG1—sarcoma	0.000119	0.00294	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCR4—sarcoma	0.000116	0.00287	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ATF1—sarcoma	0.000115	0.00284	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MDM2—sarcoma	0.000113	0.00279	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MDM2—sarcoma	0.000113	0.00278	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000108	0.00266	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CREB1—sarcoma	0.000106	0.0026	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PLCG1—sarcoma	0.000105	0.00258	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—CREB1—sarcoma	0.000105	0.00258	CbGpPWpGaD
Glycine—SHMT1—Disease—PLCG1—sarcoma	0.000102	0.00251	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ENO2—sarcoma	0.000101	0.00248	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HBA1—sarcoma	0.0001	0.00246	CbGpPWpGaD
Glycine—GSS—Metabolism—ENO2—sarcoma	9.81e-05	0.00242	CbGpPWpGaD
Glycine—SHMT1—Disease—CXCR4—sarcoma	9.8e-05	0.00241	CbGpPWpGaD
Glycine—GSS—Metabolism—HBA1—sarcoma	9.75e-05	0.0024	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1R—sarcoma	9.03e-05	0.00223	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MDM2—sarcoma	8.65e-05	0.00213	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FOXO1—sarcoma	8.6e-05	0.00212	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—sarcoma	8.59e-05	0.00212	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PDGFRB—sarcoma	8.58e-05	0.00212	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PLCG1—sarcoma	8.54e-05	0.0021	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PDGFRA—sarcoma	8.45e-05	0.00208	CbGpPWpGaD
Glycine—GSS—Metabolism—PLCG1—sarcoma	8.32e-05	0.00205	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	8.24e-05	0.00203	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—sarcoma	8.12e-05	0.002	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—sarcoma	7.8e-05	0.00192	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—sarcoma	7.32e-05	0.0018	CbGpPWpGaD
Glycine—SHMT1—Disease—FOXO1—sarcoma	7.24e-05	0.00178	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFRB—sarcoma	7.22e-05	0.00178	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—sarcoma	7.11e-05	0.00175	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFRA—sarcoma	7.11e-05	0.00175	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KIT—sarcoma	6.55e-05	0.00161	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—sarcoma	6.55e-05	0.00161	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CREB1—sarcoma	6.24e-05	0.00154	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—sarcoma	6.22e-05	0.00153	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—sarcoma	6.2e-05	0.00153	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—sarcoma	5.97e-05	0.00147	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—sarcoma	5.64e-05	0.00139	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—sarcoma	5.51e-05	0.00136	CbGpPWpGaD
Glycine—SHMT1—Disease—CREB1—sarcoma	5.25e-05	0.00129	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MDM2—sarcoma	5.16e-05	0.00127	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—sarcoma	4.79e-05	0.00118	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—sarcoma	4.75e-05	0.00117	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—sarcoma	4.61e-05	0.00114	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—sarcoma	4.49e-05	0.00111	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUN—sarcoma	4.48e-05	0.00111	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—sarcoma	4.45e-05	0.0011	CbGpPWpGaD
Glycine—SHMT1—Disease—MDM2—sarcoma	4.34e-05	0.00107	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—sarcoma	4.02e-05	0.000991	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—sarcoma	3.92e-05	0.000966	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—sarcoma	3.87e-05	0.000954	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—sarcoma	3.75e-05	0.000923	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—sarcoma	3.6e-05	0.000888	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—sarcoma	3.53e-05	0.000869	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—sarcoma	3.39e-05	0.000834	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—sarcoma	3.33e-05	0.000821	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—sarcoma	3.26e-05	0.000803	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—sarcoma	3.03e-05	0.000748	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—sarcoma	2.97e-05	0.000731	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—sarcoma	2.96e-05	0.00073	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—sarcoma	2.83e-05	0.000698	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—sarcoma	2.8e-05	0.000691	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—sarcoma	2.38e-05	0.000587	CbGpPWpGaD
